GlassScriptPhysician profile
Saniya Shaikh
NPI 1124446588
$4,743.43
in general payments reported to CMS, 2019-2025
14 companies · $515 in 2025
The $515 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $123 · 2021: $911 · 2022: $784 · 2023: $1,187 · 2024: $645 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,348.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,815.55 | 2019-2025 | Skyrizi, Rinvoq |
| E.R. Squibb & Sons, L.L.C. | $612.12 | 2023-2025 | Sotyktu |
| Ucb, INC. | $498.50 | 2019-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $337.70 | 2019-2022 | |
| Incyte Corporation | $246.10 | 2022-2025 | Opzelura |
| Galderma Laboratories, L.P. | $244.69 | 2021-2025 | Nemluvio |
| Pfizer INC. | $222.00 | 2022-2023 | |
| Genzyme Corporation | $167.78 | 2021-2022 | |
| Kyowa Kirin, INC. | $123.08 | 2020 | |
| Journey Medical Corporation | $122.69 | 2021 | |
| Arcutis Biotherapeutics, INC. | $117.15 | 2024 | Zoryve |
| Lilly USA, LLC | $114.38 | 2023 | |
| Dermavant Sciences, INC. | $99.37 | 2023 | Vtama |
| Stemline Therapeutics INC. | $22.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saniya Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.